Showing results (2011-2020 of 3,148) with videos related to
Sort By:
Pageof 315
The Journal of Molecular Diagnostics : JMD|July 3, 2016
Challenges in Determining Genotypes for Pharmacogenetics in Allogeneic Hematopoietic Cell Transplant RecipientsLoralie J Langman, Lior Nesher, Dimpy P Shah, et al.Biorxiv : the Preprint Server for Biology|April 24, 2023
Single-cell DNA replication dynamics in genomically unstable cancersAdam C Weiner, Marc J Williams, Hongyu Shi, et al.The Journal of Clinical Endocrinology and Metabolism|July 26, 2014
Preoperative neck ultrasound in clinical node-negative differentiated thyroid cancerLaura Y Wang, Frank L Palmer, Dorothy Thomas, et al.Cancer|March 22, 2016
Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicityCharles A Schiffer, Jorge E Cortes, Andreas Hochhaus, et al.American Journal of Ophthalmology|March 6, 2016
Postinjection Endophthalmitis Rates and Characteristics Following Intravitreal Bevacizumab, Ranibizumab, and AfliberceptNadim Rayess, Ehsan Rahimy, Philip Storey, et al.Malaria Journal|November 19, 2015
The effectiveness of long-lasting, insecticide-treated nets in a setting of pyrethroid resistance: a case-control study among febrile children 6 to 59 months of age in Machinga District, MalawiDon P Mathanga, Dyson A Mwandama, Andy Bauleni, et al.The British Journal of Ophthalmology|November 21, 2015
Incidence and clinical features of post-injection endophthalmitis according to diagnosisNadim Rayess, Ehsan Rahimy, Chirag P Shah, et al.JAMA Otolaryngology-- Head & Neck Surgery|June 12, 2020
Host Factors Independently Associated With Prognosis in Patients With Oral Cavity CancerCristina Valero, Daniella K Zanoni, Anjali Pillai, et al.Biorxiv : the Preprint Server for Biology|November 19, 2025
Improved interpretability in LFADS models using a learned, context-dependent per-trial biasNishal P Shah, Benyamin Abramovich Krasa, Erin Kunz, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 29, 2025
Infigratinib low dose therapy is an effective strategy to treat hypochondroplasiaBenoit Demuynck, Bhavik P Shah, Franck Mayeux, et al.Pageof 315